Phase I study of MGCD0103 given as a three-times-per-week oral dose in patients with advanced solid tumors (Q36408642)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase I study of MGCD0103 given as a three-times-per-week oral dose in patients with advanced solid tumors
scientific article

    Statements

    Phase I study of MGCD0103 given as a three-times-per-week oral dose in patients with advanced solid tumors (English)
    Wells A Messersmith
    Gregory K Reid
    Jeffrey M Besterman
    Robert E Martell

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit